Extracranial systemic embolic events in patients with Nonvalvular Atrial Fibrillation: Incidence, risk factors, and outcomes

Circulation

Volumn 132, Issue 9, 2015, Pages 796-803

  Bekwelem, Wobo ^a   Connolly, Stuart J ^b   Halperin, Jonathan L ^c   Adabag, Selcuk ^d   Duval, Sue ^a   Chrolavicius, Susan ^b   Pogue, Janice ^b   Ezekowitz, Michael D ^e   Eikelboom, John W ^b   Wallentin, Lars G ^f   Yusuf, Salim ^b   Hirsch, Alan T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^f UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

arrhythmias, cardiac; atrial fibrillation; embolism; peripheral artery disease; risk factors

Indexed keywords

AGED; AMPUTATION; ARM; ARTICLE; ATRIAL FIBRILLATION; BRAIN EMBOLISM; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOVASCULAR SURGERY; EVENT FREE SURVIVAL; EXTRACRANIAL SYSTEMIC EMBOLIC EVENT; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LEG; MAJOR CLINICAL STUDY; MALE; MESENTERIC ARTERY; NONVALVULAR ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; SYSTEMIC DISEASE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; EMBOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DOUBLE-BLIND METHOD; EMBOLISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84940666091     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013243     Document Type: Article

References (29)

1. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM, Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997 96 2455 2461
2. Wolf PA, Abbott RD, Kannel WB, Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987 147 1561 1564
3. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE, The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995 98 476 484. doi: 10.1016/S0002-9343(99)80348-9
4. Flegel KM, Shipley MJ, Rose G, Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987 1 526 529
5. Wolf PA, Abbott RD, Kannel WB, Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991 22 983 988
6. Feinberg WM, Cornell ES, Nightingale SD, Pearce LA, Tracy RP, Hart RG, Bovill EG, Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Stroke 1997 28 1101 1106
7. Abbott WM, Maloney RD, McCabe CC, Lee CE, Wirthlin LS, Arterial embolism: a 44 year perspective. Am J Surg 1982 143 460 464
8. Frost L, Engholm G, Johnsen S, Møller H, Henneberg EW, Husted S, Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med 2001 161 272 276
9. Guyton AC, Hall JE, Textbook of Medical Physiology 1996 Philadelphia Saunders Company
10. Hart RG, Halperin JL, Atrial fibrillation and stroke: concepts and controversies. Stroke 2001 32 803 808
11. Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW, Nasco E, Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000 10 39 43. doi: 10.1159/000016023
12. Active Investigators Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S, Active Investigators Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009 360 2066 2078
13. Active writing group of the ACTIVE investigators Connolly SJ, Pogue J, Hart RG, Pfeffer M, Honloser S, Chrolavicius S, Yusuf S, Active writing group of the ACTIVE investigators Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Ibersatan for prevention of Vascular events (ACTIVE W): a randomised controlled trial. Lancet 2006 367 1903 1912
14. ACTIVE I Investigators Yusuf S, Healey JS, Pogue J, Chrolavicius S, Flather M, Hart RG, Hohnloser SH, Joyner CD, Pfeffer MA, Connolly SJ, ACTIVE I Investigators Irbesartan in patients with atrial fibrillation. N Engl J Med 2011 364 928 938
15. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S, AVERROES Steering Committee and Investigators Apixaban in patients with atrial fibrillation. N Engl J Med 2011 364 806 817. doi: 10.1056/NEJMoa1007432
16. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, RE-LY Steering Committee and Investigators Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009 361 1139 1151. doi: 10.1056/NEJMoa0905561
17. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J, Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994 14 54 59
18. Stone MC, Thorp JM, Plasma fibrinogen-a major coronary risk factor. J R Coll Gen Pract 1985 35 565 569
19. Ariëns RA, Kohler HP, Mansfield MW, Grant PJ, Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999 19 2012 2016
20. Tapson VF, The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005 2 71 77
21. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010 137 263 272. doi: 10.1378/chest.09-1584
22. Hirsch AT, Allison MA, Gomes AS, Corriere MA, Duval S, Ershow AG, Hiatt WR, Karas RH, Lovell MB, McDermott MM, Mendes DM, Nussmeier NA, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Epidemiology and Prevention A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association. Circulation 2012 125 1449 1472. doi: 10.1161/CIR.0b013e31824c39ba
23. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr., Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002 40 976 982
24. Violi F, Daví G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S, ARAPACIS Study Investigators Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol 2013 62 2255 2256. doi: 10.1016/j.jacc.2013.07.035
25. Albertsen IE, Rasmussen LH, Overvad TF, Graungaard T, Larsen TB, Lip GY, Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis. Stroke 2013 44 1329 1336. doi: 10.1161/STROKEAHA.113.000883
26. Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, Becker RC, Singer DE, Halperin JL, Hacke W, Nessel CC, Berkowitz SD, Mahaffey KW, Fox KA, Califf RM, Piccini JP, ROCKET-AF Steering Committee and Investigators Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J 2015 36 288 296. doi: 10.1093/eurheartj/ehu359
27. Chu PL, Wei YF, Huang JW, Chen SI, Chu TS, Wu KD, Clinical characteristics of patients with segmental renal infarction. Nephrology (Carlton) 2006 11 336 340. doi: 10.1111/j.1440-1797.2006.00586.x
28. Duval S, Massaro JM, Jaff MR, Boden WE, Alberts MJ, Califf RM, Eagle KA, D'Agostino RB Sr, Pedley A, Fonarow GC, Murabito JM, Steg PG, Bhatt DL, Hirsch AT, REACH Registry Investigators An evidence-based score to detect prevalent peripheral artery disease (PAD). Vasc Med 2012 17 342 351. doi: 10.1177/1358863X12445102
29. National Stroke Association The Complete Guide to Stroke 2003 Englewood, CO National Stroke Association 3